Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine

European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

(2013) David Coghill et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis

(2013) Juliana Setyawan et al.   JOURNAL OF MEDICAL ECONOMICS

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

(2011) Robert L. Findling et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHD

(2011) C. J. Kratochvil et al.   PEDIATRICS

Statistical approaches for conducting network meta-analysis in drug development

(2011) Byron Jones et al.   PHARMACEUTICAL STATISTICS

Once-Daily Atomoxetine for Treating Pediatric Attention-Deficit/Hyperactivity Disorder: Comparison of Morning and Evening Dosing

(2009) Stan L. Block et al.   CLINICAL PEDIATRICS

Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia

(2009) Ferenc Martenyi et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review

(2009) Marina Danckaerts et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

(2009) Stephen V. Faraone et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study

(2009) Grazia Dell'Agnello et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Randomized, Double-Blind, Placebo-Controlled Study of Atomoxetine in Japanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

(2009) Michihiro Takahashi et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Methylphenidate Transdermal System in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder

(2009) Robert L. Findling et al.   JOURNAL OF CLINICAL PSYCHIATRY

Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response

(2008) Jeffrey H. Newcorn et al.   AMERICAN JOURNAL OF PSYCHIATRY

Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder

(2008) M. E. Bangs et al.   PEDIATRICS

Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey

(2008) David Coghill et al.   Child and Adolescent Psychiatry and Mental Health